A COVID-19 vaccine candidate developed by the US company Moderna and the National Institutes of Health starts its final phase of testing today. It's one of a handful of candidates to reach this stage.
No comments yet. Be the first to comment!
Users invited can see your content
Related chunks with this resource
No comments yet. Be the first to comment!